Mineralys Therapeutics
Mineralys Therapeutics develops aldosterone synthase inhibitors for hypertension treatment targeting CKD patients.
Open Positions (19)
·Remote - US Remote·$180k - $215k/year
·Remote - US Remote·$180k - $215k/year
·Remote - US Remote·$180k - $215k/year
·Remote - US Remote·$180k - $215k/year
·Remote - US Remote·$180k - $215k/year
·Remote - US Remote·$180k - $215k/year
·Remote - US Remote·$180k - $215k/year
·Remote - US Remote·$180k - $215k/year
·Remote - US Remote·$180k - $215k/year
·Remote - US Remote·$180k - $215k/year
·Remote - US Remote·$180k - $215k/year
·Remote - US Remote·$190k - $225k/year
·Remote - US Remote·$190k - $225k/year
·Remote - US Remote·$390k - $415k/year
·Remote - US Remote·$180k - $200k/year
·Remote - US Remote·$215k - $240k/year
·Remote - US Remote·$134k - $145k/year
·Remote - US Remote·$130k - $165k/year
·Remote - US Remote·$340k - $370k/year
Get Started Free
No credit card. Takes 10 seconds.